Ultralife Corporation
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-5.9M | $6.3M | $7.2M | $-119.0K | $-234.0K | $5.2M | $5.2M | $24.9M |
| Depreciation & Amortization | — | — | $3.9M | $4.5M | $3.5M | $2.9M | $2.7M | $2.4M |
| Depreciation | $4.0M | $3.1M | $3.0M | $3.2M | $2.9M | $2.3M | $2.2M | $2.0M |
| Amortization | $1.5M | $1.0M | $889.0K | $1.3M | $633.0K | $595.0K | $525.0K | $397.0K |
| Stock-Based Compensation | $935.0K | $698.0K | $528.0K | $776.0K | $671.0K | $943.0K | $753.0K | $890.0K |
| Net Cash from Operating Activities | $11.0M | $16.6M | $1.9M | $-1.3M | $4.3M | $21.7M | $-3.0M | $10.9M |
| Investing Activities | ||||||||
| Capital Expenditures | $3.9M | $1.9M | $2.6M | $1.7M | $2.8M | $3.1M | $6.3M | $4.2M |
| Business Acquisitions | $0 | $48.0M | $0 | $0 | $23.5M | $0 | $25.2M | — |
| Net Cash from Investing Activities | $-3.9M | $-50.0M | $-2.6M | $-1.7M | $-26.3M | $-3.0M | $-31.5M | $-4.2M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | $0 | $2.0M | $742.0K |
| Net Cash from Financing Activities | $-4.7M | $29.9M | $5.5M | $518.0K | $19.6M | $-15.7M | $16.1M | $1.2M |
| Net Change in Cash | $2.5M | $-3.4M | $4.6M | $-2.7M | $-2.2M | $3.2M | $-18.5M | $7.6M |
| Free Cash Flow | $7.1M | $14.7M | $-623.0K | $-2.9M | $1.5M | $18.6M | $-9.3M | $6.7M |